“…Brain iron levels are known to be disturbed in multiple sclerosis (MS) (Filippi et al, 2019; Hagemeier, Geurts, & Zivadinov, 2012; Zecca, Youdim, Riederer, Connor, & Crichton, 2004). Most studies reported increased iron concentrations in the deep gray matter (DGM) (Stankiewicz, Neema, & Ceccarelli, 2014) and around plaques (Craelius, Migdal, Luessenhop, Sugar, & Mihalakis, 1982), and reduced iron concentrations within lesions (Haider et al, 2014; Kutzelnigg et al, 2005; Laule et al, 2013; Yao et al, 2012; Yao et al, 2014), in the normal‐appearing white matter (WM) (Hametner et al, 2013; Paling et al, 2012; Popescu et al, 2017; Yu et al, 2018), and in the thalamus (Bergsland et al, 2018; Burgetova et al, 2017; Khalil et al, 2015; Louapre et al, 2017; Pontillo et al, 2019; Schweser et al, 2018; Uddin, Lebel, Seres, Blevins, & Wilman, 2016; Zivadinov et al, 2018). The literature considers findings of increased region‐average iron concentrations as evidence for iron influx (Bergsland et al, 2019; Ndayisaba, Kaindlstorfer, & Wenning, 2019; Williams, Buchheit, Berman, & LeVine, 2012), whereas it is less clear how to interpret reduced iron concentrations.…”